EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access · CC BY-NC-ND 4.0

Comparative effects of metformin and lifestyle therapy on bone metabolism markers: A 6-month pilot, open-label randomized-clinical trial

Mohammed Almosfer, Shaun Sabico, Kaiser Wani, Malak Nawaz K Khattak, Ibrahim S Almarashad, Nicola Veronese, Nasser M Al-Daghri

Aging Clinical and Experimental Research · 31.05.2026 · 38 (1)

DOI: 10.1007/s40520-026-03423-2 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Aging Clinical and Experimental Research, online erschienen am 31.05.2026. Verfasst von Mohammed Almosfer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Metformin, Diabetes Mellitus, Type 2, Hypoglycemic Agents, Bone Remodeling. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ongoing Research Funding Program-Research Chairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminDiabetes Mellitus, Type 2Hypoglycemic AgentsBone RemodelingLife StyleBone and BonesHumansFemaleMiddle AgedPilot ProjectsMaleBiomarkersAdultCollagen Type IProcollagenPeptide Fragments

Stichwörter der Autor:innen

Bone turnover markersCTXLifestyle interventionMetforminP1NPRandomized controlled trialType 2 diabetes mellitus

Substanzen

MetforminBiomarkersHypoglycemic Agentsprocollagen Type I N-terminal peptideCollagen Type IProcollagenPeptide Fragments

Autor:innen und Institutionen

  • Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia.
  • Ministry of Health, Buraydah, Saudi Arabia.
  • Saint Camillus International University of Health Sciences, Via di Sant'Alessandro 8, Roma, Italy.
  • Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia. ndaghri@ksu.edu.sa.

Förderung

  • Ongoing Research Funding Program-Research Chairs

Zitieren

APA

Almosfer, M., Sabico, S., Wani, K., Khattak, M. N. K., Almarashad, I. S., Veronese, N., & Al-Daghri, N. M. (2026). Comparative effects of metformin and lifestyle therapy on bone metabolism markers: A 6-month pilot, open-label randomized-clinical trial. Aging Clinical and Experimental Research, 38(1). https://doi.org/10.1007/s40520-026-03423-2

Vancouver

Almosfer M, Sabico S, Wani K, Khattak MNK, Almarashad IS, Veronese N, et al. Comparative effects of metformin and lifestyle therapy on bone metabolism markers: A 6-month pilot, open-label randomized-clinical trial. Aging Clinical and Experimental Research. 2026;38(1). doi:10.1007/s40520-026-03423-2

BibTeX
@article{Almosfer2026,
  author = {Almosfer, Mohammed and Sabico, Shaun and Wani, Kaiser and Khattak, Malak Nawaz K and Almarashad, Ibrahim S and Veronese, Nicola and Al-Daghri, Nasser M},
  title = {Comparative effects of metformin and lifestyle therapy on bone metabolism markers: A 6-month pilot, open-label randomized-clinical trial},
  journal = {Aging Clinical and Experimental Research},
  year = {2026},
  volume = {38},
  number = {1},
  doi = {10.1007/s40520-026-03423-2}
}
Kostenlos starten →